Buy LLY by Oct 22, 2026.

All this drawdown has made me realize I don't hold anything in healthcare. So I started buying LLY this past month and now this week started getting into GENB. $LLY - solid long-term stock, kind of overvalued in a P/E to EV/EBITDA sense compared to its market comparables, but if you look at its PEG ratio due to its huge growth, it feels fairly priced. Big player has a lot of room to grow in the fat-loss industry as it …